Touraj Yari
Medical · San Diego, CANPI 1508214958
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 1,429 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,429 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- UCB, Inc.$3K
- Amgen$1K
- Biogen$1K
- Lundbeck LLC$1K
- Teva Pharmaceuticals USA, Inc.$1K
- plus $15K from 54 others
What the payments were for
- Food & beverage$26,33699%
- Education$3761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$255
- Inspire Upper Airway Stimulation System$175
- Ponvory$160
- Vumerity$135
- NUPLAZID$125
- NURTEC ODT$124
- NEUROMARK Device$115
- NEUROMARK Radiofrequency Console$115
- XPRESS ENT DILATION SYSTEM$111
- AUSTEDO$104
- Inspire$103
- INFINITY$101
How this compares
$26,713 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 28 | $488,703 |
| PanzygaImmun Glob G(Igg)-Ifas/Glycine | 13 | $230,117 |
| KeveyisDichlorphenamide | 12 | $227,803 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $130,002 |
| PonvoryPonesimod | 11 | $98,956 |
| Emgality PenGalcanezumab-Gnlm | 78 | $54,874 |
| Aimovig AutoinjectorErenumab-Aooe | 31 | $37,393 |
| HorizantGabapentin Enacarbil | 29 | $29,047 |
| RytaryCarbidopa/Levodopa | 23 | $24,301 |
| Nurtec OdtRimegepant Sulfate | 23 | $21,946 |
| QuliptaAtogepant | 12 | $13,123 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 11 | $12,819 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $12,321 |
| NamzaricMemantine Hcl/Donepezil Hcl | 12 | $6,778 |
| Gabapentin | 343 | $4,447 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra, Privigen | $439 | $618,70639 claims |
| PfizerPanzyga, Nurtec Odt | $628 | $252,06336 claims |
| Xeris Pharmaceuticals, Inc.Keveyis | $44 | $227,80312 claims |
| Johnson & JohnsonPonvory | $376 | $98,95611 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $42 | $29,04729 claims |
| Amneal Pharmaceuticals LLCRytary | $103 | $24,30123 claims |
| AbbVieQulipta, Namzaric | $3,339 | $19,90124 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $58 | $12,32111 claims |
| Upsher-smith Laboratories LLCTopiramate | $311 | $55066 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in San Diego
- Cheryl KyinnSan Diego$103K
- Aaron WillcottSan Diego$23K
- Yuchao JinSan Diego$22K
- Carter CopelandSan Diego$17K
- Cameron ChanSan Diego$16K
- Melanie GloverSan Diego$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.